4 results match your criteria: "Medical Center Beauty Benefit[Affiliation]"
Eur J Pharmacol
September 2017
Department of Pharmacology, Medicine College, Mutah University, Jordan.
Oxidative stress and inflammation play key roles in the pathogenesis of Multiple sclerosis (MS). Different drugs have been used in the clinical practice, however, there is not a completely effective treatment. Due to its potential therapeutic action, medical ozone represents a promising approach for neurodegenerative disorders.
View Article and Find Full Text PDFEvid Based Complement Alternat Med
September 2015
Experimental Surgery-Research Unit, Dr. Negrin University Hospital, 35.010 Las Palmas, Spain.
Introduction. Persistent radiation-induced proctitis and rectal bleeding are debilitating complications with limited therapeutic options. We present our experience with ozone therapy in the management of such refractory rectal bleeding.
View Article and Find Full Text PDFEur J Pharmacol
November 2014
Biomedical Research Laboratories, Medicine Faculty, Catholic University of Maule, Talca, Chile.
The present preliminary study has been focused on verifying whether ozone preconditioning may be linked to Nrf2/EpRE (nuclear factor erythroid 2/electrophile-responsive element) activation pathway in vivo. Healthy volunteers received a total of three Major Auto-Hemotherapy (MAH) treatments, with treatments administered every second day. The amount of blood used for each subject was standardized to the value obtained multiplying the subject׳s body weight by 1.
View Article and Find Full Text PDFSultan Qaboos Univ Med J
August 2014
Medical Center Beauty Benefit, Osimo, Ancona, Italy.
Objectives: Induced dilated cardiomyopathy is the main limitation of the anti-cancer drug doxorubicin, which causes oxidative stress and cardiomyocyte death. As ozone therapy can activate the antioxidant systems, this study aimed to investigate the therapeutic efficacy of ozone-oxidative preconditioning against doxorubicin-induced cardiotoxicity.
Methods: The study was carried out from September 2013 to January 2014.